Clinical Benefit and Revenues of Drugs Affected by Rare Pediatric Disease Priority Review Vouchers, 2017-2023. Liu ITT, Kesselheim AS. J Pediatr 2024;275:114211.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liu ITT, Kesselheim AS. Clinical Benefit and Revenues of Drugs Affected by Rare Pediatric Disease Priority Review Vouchers, 2017-2023. J Pediatr 2024;275:114211.
PMID: 39059716